Business Description
Pharmala Biotech Holdings Inc
NAICS : 541714
SIC : 3741
ISIN : CA71719L1067
Description
Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. PharmAla's drug API is manufactured and encapsulated under GMP conditions. The Company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -1.22 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 6.66 | |||||
| Beneish M-Score | 3.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.7 | |||||
| 9-Day RSI | 45.51 | |||||
| 14-Day RSI | 46.9 | |||||
| 6-1 Month Momentum % | 88.45 | |||||
| 12-1 Month Momentum % | -51.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | |||||
| Quick Ratio | 0.59 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 93.91 | |||||
| Days Sales Outstanding | 35.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.12 | |||||
| Operating Margin % | -20.84 | |||||
| Net Margin % | -47.31 | |||||
| FCF Margin % | -71.76 | |||||
| ROE % | -41.29 | |||||
| ROA % | -25.36 | |||||
| ROIC % | -13.47 | |||||
| ROC (Joel Greenblatt) % | -12136.36 | |||||
| ROCE % | -18.19 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 13.33 | |||||
| PB Ratio | 13.33 | |||||
| EV-to-EBIT | -68.1 | |||||
| EV-to-EBITDA | -87 | |||||
| EV-to-Revenue | 14.2 | |||||
| EV-to-FCF | -19.92 | |||||
| Earnings Yield (Greenblatt) % | -1.47 | |||||
| FCF Yield % | -5.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MDXXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmala Biotech Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.942 | ||
| EPS (TTM) ($) | -0.005 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 46.9 | ||
| 14-Day ATR ($) | 0.017997 | ||
| 20-Day SMA ($) | 0.14609 | ||
| 12-1 Month Momentum % | -51.56 | ||
| 52-Week Range ($) | 0.0316 - 0.54 | ||
| Shares Outstanding (Mil) | 91.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmala Biotech Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmala Biotech Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharmala Biotech Holdings Inc Frequently Asked Questions
What is Pharmala Biotech Holdings Inc(MDXXF)'s stock price today?
The current price of MDXXF is $0.14. The 52 week high of MDXXF is $0.54 and 52 week low is $0.03.
When is next earnings date of Pharmala Biotech Holdings Inc(MDXXF)?
The next earnings date of Pharmala Biotech Holdings Inc(MDXXF) is .
Does Pharmala Biotech Holdings Inc(MDXXF) pay dividends? If so, how much?
Pharmala Biotech Holdings Inc(MDXXF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers